Trial Profile
A phase II, open label, single site light dose escalation trial of single dose Verteporfin Photodynamic Therapy (PDT) in primary soft tissue sarcoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs Verteporfin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 23 Jun 2011 New trial record